WPW
JAZZ icon

Warther Private Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

Warther Private Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,150
Closed -$265K – 78
2024
Q4 		$265K Sell
2,150
-31,065
-94% -$3.66M 0.09% 71
2024
Q3 		$3.7M Buy
+33,215
New +$3.64M 1.3% 22

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Warther Private Wealth's JAZZ Position: Q1 2025 in Review

Warther Private Wealth sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 2,150 shares — an estimated $265K sold.

Warther Private Wealth first reported a position in JAZZ in Q3 2024 and held it in 2 quarters. The position peaked at $3.7M in Q3 2024. 551 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • Warther Private Wealth reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Warther Private Wealth sold 2,150 Jazz Pharmaceuticals shares in Q1 2025, an estimated $265K.
  • Warther Private Wealth first reported a position in Jazz Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Warther Private Wealth's Jazz Pharmaceuticals position peaked at $3.7M in Q3 2024.
  • 551 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on Warther Private Wealth's 13F filing for Q1 2025, filed 17 Apr 2025.